Dorothy Pan, MD

Dorothy Pan, MD
Appointed 08/01/11
Women's Health Network
2275 Regional Oncology Center
750 East Adams Street
Syracuse, NY 13210

315 464-8668

Current Appointments

Hospital Campus

  • Downtown

Clinical Section Affiliations

  • Medicine: Hematology and Oncology
  • Upstate Cancer Center: Medical Oncology


Education & Fellowships

  • Fellowship: Memorial Sloan-Kettering Cancer Center, 2001, Medical Oncology and Hematology
  • Residency: Albert Einstein/Montefiore Medical Center, 1998, Internal Medicine
  • MD: Cornell University Medical College, 1995
  • BA: Massachusetts Institute of Technology, 1991

Clinical Trials

  • Autologous Hematopoietic Stem Cell and/or Bone Marrow Transplantation after High Dose Chemotherapy (Carboplatinum, Etoposide) in Patients with Recurrent/Refractory Germ Cell Tumors.
    Read more
  • Autologous Hematopoietic Stem Cell Transplantation After Melphalan with or without Total Body Irradiation for Multiple Myeloma.
    Read more
  • Autologous Stem Cell Transplantation for Acute Myeloid Leukemia in First or Second Remission.
    Read more
  • CALGB 50801-Phase II Trial of Response-Adapted Therapy Based on Positron Emission Tomography (PET) for Bulky Stage I And Stage II Classical Hodgkin Lymphoma (HL)
    Read more
  • CALGB 50904-A Randomized Phase II Trial of Ofatumumab and Bendamustine vs. Ofatumumab, Bortezomib (NSC # 681239, IND # 58443) and Bendamustine in Patients With Untreated Follicular Lymphoma
    Read more
  • CALGB 51101-A Randomized Phase II Trial of Myeloablative Versus Non-Myeloablative Consolidation Chemotherapy for Newly Diagnosed Primary CNS B-cell Lymphoma
    Read more
  • Celgene Protocol Number: CC-5013-NHL-007 - A phase 3, double-blind randomized study to compare the efficacy and safety of rituximab plus lenalidomide (cc-5013) versus rituximab plus placebo in subjects with relapsed/refractory indolent lymphoma
    Read more
  • High Dose Cyclophosphamide, BCNU, Etoposide (CBV) or Carmustine, Etoposide, Cytarabine, Melphalan (BEAM) and Autologous Hematopoietic Stem Cell Transplantation for Resistant and Relapsed Hodgkin's Disease and Non-Hodgkin's Lymphoma.
    Read more
  • High Dose Cyclophosphamide, Thiotepa & Etoposide Followed by Autologous Hematopoietic Stem Cell Transplantation (Intermediate & High Grade).
    Read more

Specialties & Certification

  • Medical Oncology
  • Hematology

Diseases & Conditions Treated

  • All Cancers and Hematological Conditions


  • Adults


  • Chemotherapy
  • Immunotherapy

Current Hospital Privileges

  • Upstate University Hospital
  • Crouse Hospital
Clinical Profile Shortcut: http://www.upstate.edu/findadoc/pand
Faculty Profile Shortcut: http://www.upstate.edu/faculty/pand